Concepedia

Author

Jörgen Elgqvist

University of Gothenburg

Also Known As

J Elgqvist, J. Elgqvist, Jorgen Elgqvist, Jörgen Elgqvist

32

Publications

1.3K

Citations

17

H-Index

28

Concepts

All Affiliations

University of GothenburgRigshospitaletLund UniversitySahlgrenska University HospitalChalmers University of Technology
JE

About

Jörgen Elgqvist is an author at University of Gothenburg specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

250

2

Engineering

1

1

18

3

Health Sciences

1

1

46

4

Biomedical Engineering

1

1

18

5

Cell Biology

1

1

18

Jörgen Elgqvist

×

18

Publications

925

Citations

15

H-Index

YearCitations

Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of <sup>211</sup>At-MX35 F(ab′)<sub>2</sub>—A Phase I Study

Håkan Andersson, Elin Cederkrantz, Tom Bäck,

Journal of Nuclear Medicine

2009

279

Direct Procedure for the Production of<sup>211</sup>At-Labeled Antibodies with an ε-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate

Sture Lindegren, Sofia H.L. Frost, Tom Bäck,

Journal of Nuclear Medicine

2008

78

Therapeutic Efficacy of Astatine-211–Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice

Stig Palm, Tom Bäck, Ingela Claesson,

International Journal of Radiation Oncology*Biology*Physics

2007

72

Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.

Jörgen Elgqvist, Håkan Andersson, Tom Bäck,

PubMed

2005

72

Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.

Jörgen Elgqvist, Håkan Andersson, Tom Bäck,

PubMed

2006

68

Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.

Håkan Andersson, Jörgen Elgqvist, György Horváth,

PubMed

2003

50

Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model

Anna Gustafsson, Tom Bäck, Jörgen Elgqvist,

Nuclear Medicine and Biology

2011

46

Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.

Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn,

PubMed

2005

46

Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab′)2: therapeutic efficacy and myelotoxicity

Jörgen Elgqvist, Håkan Andersson, Tom Bäck,

Nuclear Medicine and Biology

2006

35

Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2

Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt,

International Journal of Radiation Oncology*Biology*Physics

2006

33

Page 1